Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System

NCT01777295 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: Adjuvanted Hepatitis B surface antigen (HBsAg) candidate vaccine GSK2231392A.
BIOLOGICAL: EngerixTM-B
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline

Collaborators

[object Object]
[object Object]